Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0409974 (
lupus
)
22,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
During the past year several novel reports have added new knowledge to our understanding of the pathogenesis of system
lupus erythematosus
(a) a novel pathway for the presentation of autoantigens to autoreactive T cells was revealed. Universally binding nucleosomal epitopes are productively recognized by autoreactive T cells by binding to the T-cell receptor-alpha chain; (b) circulating T cells from patients with
lupus
commonly display a deficiency of the
T-cell receptor zeta chain
, and upon ligation of their cell-surface antigen receptor overproduce tyrosine phosphorylated proteins; (c)
lupus
and lupus nephritis are associated with a low-binding FcgammaRIIIA (CD16) polymorphism that crosses ethnic barriers; (d) the pathogenetic role of the cytokine interleukin-10 is expanding, because it is reportedly overproduced not only by cells from
lupus
patients but also by cells from their healthy relatives, and its overproduction in vitro is correlated with increased apoptotic cell death and with lymphopenia.
...
PMID:Lymphocytes, cytokines, inflammation, and immune trafficking. 974 56
Recent studies have identified novel aberrations in antigen receptor-mediated signaling events in lymphocytes from patients with systemic lupus erythematosus. Here, we propose that in
lupus
lymphocytes, the receptor-mediated increase in protein tyrosine phosphorylation and cytoplasmic free Ca2+ responses, along with
T-cell receptor zeta chain
deficiency, might explain the previously described diverse and conflicting immunoregulatory defects in human
lupus
.
...
PMID:Immune cell signaling defects in lupus: activation, anergy and death. 1020 2